386 related articles for article (PubMed ID: 28614796)
1. α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.
Chandra R; Hiniker A; Kuo YM; Nussbaum RL; Liddle RA
JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614796
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil.
Yang Y; Zhang Z
Neural Regen Res; 2024 Jul; 19(7):1463-1472. PubMed ID: 38051888
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an
Hurley MJ; Menozzi E; Koletsi S; Bates R; Gegg ME; Chau KY; Blottière HM; Macnaughtan J; Schapira AHV
Brain Commun; 2023; 5(6):fcad285. PubMed ID: 37953845
[TBL] [Abstract][Full Text] [Related]
4. Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease.
Gallegos S; Pacheco C; Peters C; Opazo CM; Aguayo LG
Front Neurosci; 2015; 9():59. PubMed ID: 25805964
[TBL] [Abstract][Full Text] [Related]
5. Complement C1q-dependent engulfment of alpha-synuclein induces ENS-resident macrophage exhaustion and accelerates Parkinson's-like gut pathology.
Mackie PM; Koshy J; Bhogade M; Hammoor T; Hachmeister W; Lloyd GM; Paterno G; Bolen M; Tansey MG; Giasson BI; Khoshbouei H
bioRxiv; 2023 Oct; ():. PubMed ID: 37961460
[TBL] [Abstract][Full Text] [Related]
6. Gut mucosal cells transfer α-synuclein to the vagus nerve.
Chandra R; Sokratian A; Chavez KR; King S; Swain SM; Snyder JC; West AB; Liddle RA
bioRxiv; 2023 Sep; ():. PubMed ID: 37645945
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Inflammation and Parkinson's Disease.
Li Y; Chen Y; Jiang L; Zhang J; Tong X; Chen D; Le W
Aging Dis; 2021 Dec; 12(8):2052-2068. PubMed ID: 34881085
[TBL] [Abstract][Full Text] [Related]
8. Does gut brain axis has an impact on Parkinson's disease (PD)?
Elangovan A; Dahiya B; Kirola L; Iyer M; Jeeth P; Maharaj S; Kumari N; Lakhanpal V; Michel TM; Rao KRSS; Cho SG; Yadav MK; Gopalakrishnan AV; Kadhirvel S; Kumar NS; Vellingiri B
Ageing Res Rev; 2024 Feb; 94():102171. PubMed ID: 38141735
[TBL] [Abstract][Full Text] [Related]
9. Enteroendocrine cell regulation of the gut-brain axis.
Barton JR; Londregan AK; Alexander TD; Entezari AA; Covarrubias M; Waldman SA
Front Neurosci; 2023; 17():1272955. PubMed ID: 38027512
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota promotes enteroendocrine cell maturation and mitochondrial function.
Alsudayri A; Perelman S; Chura A; Brewer M; McDevitt M; Drerup C; Ye L
bioRxiv; 2023 Nov; ():. PubMed ID: 37961164
[TBL] [Abstract][Full Text] [Related]
11. Misfolded α-Synuclein Seeding Is Detected in Suspected LRRK2-Parkinson's Disease without Immunohistochemically Detectable α-Synuclein Pathology.
Kim A; Martinez-Valbuena I; Keith JL; Kovacs GG; Lang AE
Mov Disord; 2024 Jan; 39(1):218-220. PubMed ID: 37986700
[No Abstract] [Full Text] [Related]
12. Matters arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
Steiner MA
NPJ Parkinsons Dis; 2024 Mar; 10(1):59. PubMed ID: 38486022
[No Abstract] [Full Text] [Related]
13. Lymphatic propagation of α-synuclein.
Kiani L
Nat Rev Neurol; 2023 Oct; 19(10):576. PubMed ID: 37697048
[No Abstract] [Full Text] [Related]
14. Parkinson's disease from the gut.
Liddle RA
Brain Res; 2018 Aug; 1693(Pt B):201-206. PubMed ID: 29360467
[TBL] [Abstract][Full Text] [Related]
15. A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity.
Stolzenberg E; Berry D; Yang D; Lee EY; Kroemer A; Kaufman S; Wong GCL; Oppenheim JJ; Sen S; Fishbein T; Bax A; Harris B; Barbut D; Zasloff MA
J Innate Immun; 2017; 9(5):456-463. PubMed ID: 28651250
[TBL] [Abstract][Full Text] [Related]
16. T cells from patients with Parkinson's disease recognize α-synuclein peptides.
Sulzer D; Alcalay RN; Garretti F; Cote L; Kanter E; Agin-Liebes J; Liong C; McMurtrey C; Hildebrand WH; Mao X; Dawson VL; Dawson TM; Oseroff C; Pham J; Sidney J; Dillon MB; Carpenter C; Weiskopf D; Phillips E; Mallal S; Peters B; Frazier A; Lindestam Arlehamn CS; Sette A
Nature; 2017 Jun; 546(7660):656-661. PubMed ID: 28636593
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates.
Arawaka S; Sato H; Sasaki A; Koyama S; Kato T
Acta Neuropathol Commun; 2017 Jun; 5(1):48. PubMed ID: 28619113
[TBL] [Abstract][Full Text] [Related]
18. Parkinson disease: Plasma α-synuclein - a potential marker of cognitive impairment in Parkinson disease.
Wood H
Nat Rev Neurol; 2017 Aug; 13(8):450. PubMed ID: 28643805
[No Abstract] [Full Text] [Related]
19. Does Parkinson's disease start in the gut?
Lionnet A; Leclair-Visonneau L; Neunlist M; Murayama S; Takao M; Adler CH; Derkinderen P; Beach TG
Acta Neuropathol; 2018 Jan; 135(1):1-12. PubMed ID: 29039141
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
